Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase

American Journal of Physiology - Endocrinology and Metabolism

Volumn 297, Issue 2, 2009, Pages

  Luria, Ayala ^a   Morisseau, Christophe ^a   Tsai, Hsing Ju ^a   Yang, Jun ^a   Inceoglu, Bora ^a   De Taeye, Bart ^c   Watkins, Steven M ^b   Wiest, Michelle M ^d   German, J Bruce ^a   Hammock, Bruce D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Lipomics Inc   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF IDAHO   (United States)

Author keywords

Cholesterol; Fertility

Indexed keywords

CHOLESTEROL; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; TESTOSTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BLOOD VESSEL TONE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE DISRUPTION; GENE EXPRESSION; GENOTYPE; HEART MUSCLE CONTRACTILITY; HYDROLYSIS; KIDNEY TUBULE ABSORPTION; LIPID COMPOSITION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEGREGATION ANALYSIS; SEMEN ANALYSIS; SPERMATOZOON COUNT; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CHOLESTEROL; EICOSANOIDS; EPOXIDE HYDROLASES; EPOXY COMPOUNDS; FEMALE; FERTILITY; GENOTYPE; HYDROLYSIS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SOLUBILITY; TESTOSTERONE;

EID: 68049090765     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00131.2009     Document Type: Article

References (64)

1. Ahn KC, Zhao B, Chen J, Cherednichenko G, Sanmarti E, Denison MS, Lasley B, Pessah IN, Kultz D, Chang DP, Gee SJ, Hammock BD. in vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. Environ Health Perspect 116: 1203-1210, 2008.
2. Bhathena SJ. Relationship between fatty acids and the endocrine system. Biofactors 13: 35-39, 2000.
3. Borhan B, Mebrahtu T, Nazarian S, Kurth MJ, Hammock BD. Improved radiolabeled substrates for soluble epoxide hydrolase. Anal Biochem 231: 188-200, 1995.
4. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
5. Chen J, Ahn KC, Gee NA, Ahmed MI, Duleba AJ, Zhao L, Gee SJ, Hammock BD, Lasley BL. Triclocarban enhances testosterone action: a new type of endocrine disruptor? Endocrinology 149: 1173-1179, 2008.
6. Chiamvimonvat N, Ho CM, Tsai HJ, Hammock BD. The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Cardiovasc Pharmacol 50: 225-237, 2007.
7. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator- activated receptors (PPARs): nuclear receptors with functions in the vascular wall. Z Kardiol 90, Suppl 3: 125-132, 2001.
8. Cronin A, Mowbray S, Durk H, Homburg S, Fleming I, Fisslthaler B, Oesch F, Arand M. The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase. Proc Natl Acad Sci USA 100: 1552-1557, 2003.
9. D'Aquila PS, Brain P, Willner P. Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol Behav 56: 861-867, 1994.
10. Davis BB, Thompson DA, Howard LL, Morisseau C, Hammock BD, Weiss RH. Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 99: 2222-2227, 2002.
11. De Taeye BM, Novitskaya T, McGuinness OP, Gleaves L, Medda M, Covington JW, Vaughan DE. Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab 293: E713-E725, 2007.
12. Denlinger CL, Vesell ES. Hormonal regulation of the developmental pattern of epoxide hydrolases. Studies in rat liver. Biochem Pharmacol 38: 603-610, 1989.
13. DiBiasio KW, Silva MH, Shull LR, Overstreet JW, Hammock BD, Miller MG. Xenobiotic metabolizing enzyme activities in rat, mouse, monkey, and human testes. Drug Metab Dispos 19: 227-232, 1991.
14. Du Teaux SB, Newman JW, Morisseau C, Fairbairn EA, Jelks K, Hammock BD, Miller MG. Epoxide hydrolases in the rat epididymis: possible roles in xenobiotic and endogenous fatty acid metabolism. Toxicol Sci 78: 187-195., 2004.
15. Enayetallah AE, Cao L, Grant DF. Novel role of soluble epoxide hydrolase in regulating cholesterol in mammalian cells. Open Drug Metab J 1: 1-6, 2007.
16. Enayetallah AE, Grant DF. Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis. Biochem Biophys Res Commun 341: 254-260, 2006.
17. Enayetallah AE, Luria A, Luo B, Tsai HJ, Sura P, Hammock BD, Grant DF. Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase. J Biol Chem 283: 36592-36598, 2008.
18. EnayetAllah AE, Sura P, Grant DF. Role of soluble epoxide hydrolase in regulating the isoprenoid biosynthesis pathway and its downstream effects. Drug Metab Rev 38: 202-203, 2006.
19. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
20. Frye CA, Edinger K, Sumida K. Androgen administration to aged male mice increases anti-anxiety behavior and enhances cognitive performance. Neuropsychopharmacology 33: 1049-1061, 2008.
21. Frye CA, Paris JJ, Rhodes ME. Engaging in paced mating, but neither exploratory, anti-anxiety, nor social behavior, increases 5 alpha-reduced progestin concentrations in midbrain, hippocampus, striatum, and cortex. Reproduction 133: 663-674, 2007.
22. Frye CA, Rhodes ME, Petralia SM, Walf AA, Sumida K, Edinger KL. 3 Alpha-hydroxy-5 alpha-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors. Neuroscience 138: 1007-1014, 2006.
23. Frye CA, Walf AA, Rhodes ME, Hamey JP. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 15 alpha-reductase. Brain Res 1004: 116-124, 2004.
24. Fulton D, McGiff JC, Quilley J. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart. J Pharmacol Exp Ther 287: 497-503, 1998.
25. Gazouli M, Yao ZX, Boujrad N, Corton JC, Culty M, Papadopoulos V. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology 143: 2571-2583, 2002.
26. Gill SS, Hammock BD. Distribution and properties of a mammalian soluble epoxide hydrase. Biochem Pharmacol 29: 389-395, 1980.
27. Gill SS, Hammock BD, Yamamoto I, Casida JE. Preliminary chromatographic studies on the metabolites and photodecomposition products of the juvenoid 1-(4′-ethylphenoxy-6,7-epoxy)-3,7-dimethyl-2-octene. In: Insect Juvenile Hormones: Chemistry and Action, edited by Menn JJ and Beroza M. New York: Academic, 1972, p. 177-189.
28. Grant DF, Storms DH, Hammock BD. Molecular cloning and expression of murine liver soluble epoxide hydrolase. J Biol Chem 268: 17628-17633, 1993.
29. Gronli J, Murison R, Fiske E, Bjorvatn B, Sorensen E, Portas CM, Ursin R. Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol Behav 84: 571-577, 2005.
30. Guenthner TM, Hammock BD, Vogel U, Oesch F. Cytosolic and microsomal epoxide hydrolases are immunologically distinguishable from each other in the rat and mouse. J Biol Chem 256: 3163-3166, 1981.
31. Hammock BD, Ota K. Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities. Toxicol Appl Pharmacol 71: 254-265, 1983.
32. Hammock BD, Gill SS, Mumby SM, Ota K. Comparison of epoxide hydrases in the soluble and microsomal fractions of mammalian liver. In: Molecular Basis of Environmental Toxicity, edited by Bhatnagar RS. Ann Arbor, MI: Ann Arbor Science Publishers, 1980, p. 229-272.
33. Imig JD, Zhao X, Zaharis CZ, Olearczyk JJ, Pollock DM, Newman JW, Kim IH, Watanabe T, Hammock BD. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 46: 975-981, 2005.
34. Inceoglu B, Schmelzer KR, Morisseau C, Jinks SL, Hammock BD. Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). Prostaglandins Other Lipid Mediat 82: 42-49, 2007.
35. Inoue N, Fujiwara K, Iwata T, Imai K, Aimoto T. Involvement of pituitary-hormone in the sex-related regulation of hepatic epoxide hydrolase activity in mice. Biol Pharmaceut Bull 18: 536-539, 1995.
36. Inoue N, Yamada K, Imai K, Aimoto T. Sex hormone-related control of hepatic epoxide hydrolase activities in mice. Biol Pharm Bull 16: 1004-1007, 1993.
37. Long JM. Analysis of neural cell function in gene knockout mice: behavior. Methods Enzymol 417: 66-79, 2006.
38. Loury DN, Moody DE, Kim BW, Hammock BD. Effect of dietary clofibrate on epoxide hydrolase activity in tissues of mice. Biochem Pharmacol 34: 1827-1833, 1985.
39. Luria A, Rubinstein S, Lax Y, Breitbart H. Extracellular adenosine triphosphate stimulates acrosomal exocytosis in bovine spermatozoa via P2 purinoceptor. Biol Reprod 66: 429-437, 2002.
40. Luria A, Weldon SM, Kabcenell AK, Ingraham RH, Matera D, Jiang HP, Gill R, Morisseau C, Newman JW, Hammock BD. Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem 282: 2891-2898, 2007.
41. Markaverich BM, Alejandro M, Thompson T, Mani S, Reyna A, Portillo W, Sharp J, Turk J, Crowley JR. Tetrahydrofurandiols (THF-diols), leukotoxindiols (LTX-diols), and endocrine disruption in rats. Environ Health Perspect 115: 702-708, 2007.
42. Moghaddam MF, Grant DF, Cheek JM, Greene JF, Williamson KC, Hammock BD. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat Med 3: 562-566, 1997.
43. Morisseau C, Derbel M, Lane TR, Stoutamire D, Hammock BD. Differential induction of hepatic drug-metabolizing enzymes by fenvaleric acid in male rats. Toxicol Sci 52: 148-153, 1999.
44. Morisseau C, Goodrow MH, Newman JW, Wheelock CE, Dowdy DL, Hammock BD. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases. Biochem Pharmacol 63: 1599-1608, 2002.
45. Morisseau C, Hammock BD. Epoxide hydrolase. In: Wiley Encyclopedia of Molecular Medicine, edited by Creighton TE. Hoboken, NJ: Wiley and Sons, 2002, p. 1194-1997.
46. Morisseau C, Hammock BD. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol 45: 311-333, 2005.
47. Morisseau C, Newman JW, Wheelock CE, Hill T3rd, Morin D, Buckpitt AR, Hammock BD. Development of metabolically stable inhibitors of mammalian microsomal epoxide hydrolase. Chem Res Toxicol In press: 2008.
48. Morisseau CaBDH. Measurements of soluble epoxide hydrolase (sEH) activity. In: Techniques for Analysis of Chemical Biotransformation: Current Protocols in Toxicology, esdited by Bus JS, Costa LG, Hodgson E, Lawrence DA, and Reed DJ. Hoboken, NJ: Wiley & Sons, p. 4.23.21-24.23.18, 2007.
49. Newman JW, Morisseau C, Harris TR, Hammock BD. The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc Natl Acad Sci USA 100: 1558-1563, 2003.
50. Ng VY, Huang Y, Reddy LM, Falck JR, Lin ET, Kroetz DL. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. Drug Metab Disp 35: 1126-1134, 2007.
51. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276-1279, 1999.
52. O'Shaughnessy PJ, Willerton L, Baker PJ. Changes in Leydig cell gene expression during development in the mouse. Biol Reprod 66: 966-975, 2002.
53. Pinot F, Grant DF, Spearow JL, Parker AG, Hammock BD. Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice. Biochem Pharmacol 50: 501-508, 1995.
54. Potente M, Fisslthaler B, Busse R, Fleming I. 11,12- Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1. J Biol Chem 278: 29619-29625, 2003.
55. Sato K, Emi M, Ezura Y, Fujita Y, Takada D, Ishigami T, Umemura S, Xin Y, Wu LL, Larrinaga-Shum S, Stephenson SH, Hunt SC, Hopkins PN. Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred. J Hum Genet 49: 29-34, 2004.
56. Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP, Hammock BD. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA 102: 9772-9777, 2005.
57. Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, Gonzalez FJ. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275: 40504-40510, 2000.
58. Tang XD, Sanford LD. Home cage activity and activity-based measures of anxiety in 129P3/J, 129X1/SvJ and C57BL/6J mice. Physiol Behav 84: 105-115, 2005.
59. Tran KL, Aronov PA, Tanaka H, Newman JW, Hammock BD, Morisseau C. Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase. Biochemistry 44: 12179-12187, 2005.
60. Wang C, Leung A, Sinhahikim AP. Reproductive aging in the male brown-Norway rat - a model for the human. Endocrinology 133: 2773-2781, 1993.
61. Watkins SM, German JB. Toward the implementation of metabolomic assessments of human health and nutrition. Curr Opin Biotechnol 13: 512-516, 2002.
62. Watkins SM, Hammock BD, Newman JW, German JB. Individual metabolism should guide agriculture toward foods for improved health and nutrition. Am J Clin Nutr 74: 283-286, 2001.
63. Watkins SM, Reifsnyder PR, Pan HJ, German JB, Leiter EH. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J Lipid Res 43: 1809-1817, 2002.
64. Yu B, Kodavanti UP, Takeuchi M, Witschi H, Pinkerton KE. Acute tobacco smoke-induced airways inflammation in spontaneously hypertensive rats. Inhal Toxicol 20: 623-633, 2008.